Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi

Annals of Hematology

Volumn 86, Issue 12, 2007, Pages 897-903

  Rigacci, Luigi ^a   Vitolo, Umberto ^b   Nassi, Luca ^a   Merli, Francesco ^c   Gallamini, Andrea ^d   Pregno, Patrizia ^b   Alvarez, Isabel ^c   Salvi, Flavia ^e   Sancetta, Rosaria ^f   Castagnoli, Antonio ^a   Versari, Annibale ^c   Biggi, Alberto ^d   Gregianin, Michele ^f   Pelosi, Ettore ^b   Chisesi, Teodoro ^f   Bosi, Alberto ^a   Levis, Alessandro ^e  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Hematology and Nuclear Medicine   (Italy)

^d S CROCE E CARLE HOSPITAL   (Italy)

^e SS Antonio e Biagio General Hospital   (Italy)

^f SS Giovanni e Paolo Hospital   (Italy)

Author keywords

Computed tomography; FDG PET; Hodgkin's disease; Staging

Indexed keywords

DIAGNOSTIC AGENT; FLUORINE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MANAGEMENT; FEMALE; HODGKIN DISEASE; HUMAN; ITALY; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RADIOGRAPHY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; BONE MARROW; DISEASE MANAGEMENT; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; ITALY; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 40849147717     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-007-0356-9     Document Type: Article

References (24)

1. Donaldson SS, Hancock SL, Hoppe RT (1999) The Janeway lecture. Hodgkin's disease-finding the balance between cure and late effects. Cancer J Sci Am 5:325-333
2. Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7:1630-1636
3. Vinnicombe SJ, Reznek RH (2003) Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging 30(Suppl 1):S42-S55
4. Carrington B (1998) Lymph nodes. In: Husband JE, Reznek RH (eds) Imaging in oncology. Isis Medical Media, Oxford, pp 729-748
5. Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G (1999) Whole-body positron emission tomography using 18F-fluorodeoxyglucose for post-treatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 94:429-433
6. Jerusalem G, Beguin Y, Fassotte MF, Belhocine T, Hustinx R, Rigo P, Fillet G (2003) Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Ann Oncol 14:123-130
7. Rigacci L, Castagnoli A, Dini C, Carpaneto A, Matteini M, Alterini R, Carrai V, Nassi L, Bernardi F, Pieroni E, Bosi A (2005) 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long term results. Oncol Rep 14:1209-1214
8. Gallamini A, Rigacci L, Merli F, Nassi L, Bosi A, Capodanno I, Luminari S, Vitolo U, Sancetta R, Iannitto E, Trentin L, Stelitano C, Tavera S, Bigi A, Castagnoli A, Versari A, Gregianin M, Pelosi E, Torchio P, Levis A (2006) The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Haematologica 91:475-481
9. Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, Buus S, Keiding S, D'Amore F, Boesen AM, Berthelsen AK, Specht L (2006) FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 107:52-59
10. Delbeke D, Martin WH, Morgan DS, Kinney MC, Feurer I, Kovalsky E, Arrowsmith T, Greer JP (2002) 2-deoxy-2-[F-18] fluoro-D-glucose imaging with positron emission tomography for initial staging of Hodgkin's disease and lymphoma. Mol Imaging Biol 4:105-114
11. Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G (2001) Whole-body positron emission tomography using 18Ffluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica 86:266-273
12. Munker R, Glass J, Griffeth LK, Sattar T, Zamani R, Heldmann M, Shi R, Lilien DL (2004) Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease. Ann Oncol 15:1699-1704
13. Naumann R, Beuthien-Baumann B, Reiss A, Schulze J, Hanel A, Bredow J, Kuhnel G, Hanel M, Laniado M, Kotzerke J, Ehninger G (2004) Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. Br J Cancer 90:620-625
14. Partridge S, Timothy A, O'Doherty MJ, Hain SF, Rankin S, Mikhaeel G (2000) 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution. Ann Oncol 11:1273-1279
15. Raanani P, Shasha Y, Perry C, Metser U, Naparstek E, Apter S, Nagler A, Polliack A, Ben-Bassat I, Even-Sapir E (2006) Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era. Ann Oncol 17:117-122
16. Schaefer NG, Hany TF, Taverna C, Seifert B, Stumpe KD, von Schulthess GK (2004) Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restagingdo we need contrast-enhanced CT. Radiology 232:823-829
17. Young CS, Young BL, Smith SM (1998) Staging Hodgkin's disease with 18-FDG PET. Comparison with CT and surgery. Clin Positron Imaging 1:161-164
18. Hutchings M, Loft A, Hansen M, Pedersen LM, Berthelsen AK, Keiding S, D'Amore F, Boesen AM, Roemer L, Specht L (2006) Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 91:482-489
19. Carr R, Barrington SF, Madan B, O'Doherty MJ, Saunders CA, van der Walt J, Timothy AR (1998) Detection of lymphoma in bone marrow by whole body positron emission tomography. Blood 91:3340-3346
20. Pakos EE, Fotopoulos A, Ioannidis JP (2005) 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis. J Nucl Med 46:958-963
21. Kaplan LD (2002) Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care. Am J Med 112:262-268
22. Kumar R, Maillard I, Schuster SJ, Alavi A (2004) Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am 42:1083-1100
23. Isasi CR, Lu P, Blaufox MD (2005) A metaanalysis of 18F-2- deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma. Cancer 104:1066-1074
24. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Dihel V (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25: 579-586